if PhaseIIb/III trials for CVAC can be carried out for under $100M - why is Dendreon presenting such large losses quarter by quarter ?
my report listening to the investor conference, page-8
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $421.2M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 28.0¢ | $2.100M | 7.109M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 233293 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 36945 | 2 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |